Body-Composition pairs two growth hormone axis peptides, Tesamorelin and Ipamorelin, with AOD-9604, a growth hormone fragment studied specifically for lipid-metabolism research independent of the classical GH growth pathway. Together they represent both the hormonal and the metabolic sides of body-composition research.
HPLC certified
Independent analysis
Highest standard
Full traceability
Body-Composition combines Tesamorelin 10mg, Ipamorelin 5mg, and AOD-9604 5mg, pairing two growth hormone axis peptides with a lipid-metabolism-focused GH fragment studied independently of the classical growth-signaling pathway.
Tesamorelin is studied for GHRH receptor activation with particular reference to visceral adipose tissue. Ipamorelin contributes ghrelin-receptor activation to the same GH-axis research area. AOD-9604 is studied separately for lipid metabolism, independent of GH growth-signaling.
All three vials ship individually labeled and independently HPLC-verified before batch release. This product is intended strictly for laboratory research use only and is not approved for human consumption.
The Body-Composition kit pairs two growth hormone axis peptides, Tesamorelin and Ipamorelin, with AOD-9604, a growth hormone fragment studied specifically for lipid-metabolism research independent of the classical GH growth pathway. Together they represent both the hormonal and the metabolic sides of body-composition research.
Body-composition research typically looks at two separate systems: the growth hormone axis that governs lean-tissue signaling, and lipid metabolism, which growth hormone influences but does not fully explain on its own. This kit was built around that distinction, Tesamorelin and Ipamorelin represent the GH-axis side, while AOD-9604 represents a lipid-metabolism mechanism studied specifically because it does not rely on GH receptor growth-signaling to produce its research effects.
| Vial | Peptide | Strength | Research Focus |
|---|---|---|---|
| Vial 1 | Tesamorelin | 10mg | GHRH analog studied in growth hormone axis and visceral adipose tissue research. |
| Vial 2 | Ipamorelin | 5mg | Ghrelin/GH secretagogue receptor activation research. |
| Vial 3 | AOD-9604 | 5mg | Lipid metabolism research, independent of the classical GH growth-signaling pathway. |
Tesamorelin is a stabilized synthetic analog of growth hormone-releasing hormone. It is studied for GH-axis research with particular reference to visceral adipose tissue, making it the most directly body-composition-relevant peptide in this kit's GH-axis pairing, and the reason it is chosen over CJC-1295 or Sermorelin for this specific kit. Its stabilized structure is also a point of comparison for researchers examining how structural modifications to GHRH analogs affect both receptor engagement duration and tissue-specific research outcomes.
AOD-9604 is a modified fragment of human growth hormone corresponding to amino acids 176 to 191. What separates it from Tesamorelin and Ipamorelin is that its research focus is lipid metabolism specifically, studied independently of growth hormone's classical growth-signaling receptor pathway. That independence is precisely why it is paired with two GH-axis peptides rather than treated as redundant with them.
Ipamorelin's contribution to this kit is the same ghrelin-receptor activation studied throughout the site's GH-secretagogue category, selected here for its narrow off-target receptor profile relative to older secretagogues like GHRP-2. Pairing it with Tesamorelin rather than a second GHRH analog reflects the same additive, two-receptor logic used in the standard GH Secretagogue kit, GHRH-receptor activation plus ghrelin-receptor activation, applied specifically to a body-composition-focused research context where visceral adipose tissue is the variable of interest.
For metabolic research beyond the GH axis, see Metabolic Support, which pairs AOD-9604 with Retatrutide and MOTS-c instead. For the standard GH-axis pairing without the lipid-metabolism angle, see GH Secretagogue. Browse the full Peptide Bundles collection for the complete lineup.
Each of the three vials ships individually labeled with compound name, strength, and batch lot number, none are pre-mixed. Every vial is synthesized via solid-phase peptide synthesis and independently verified through HPLC before batch release. Certificates of Analysis are available per component batch on request, the same documentation provided when any of the three peptides is purchased individually.
This product is intended strictly for laboratory research use only. It is not approved for human consumption, therapeutic application, or diagnostic purposes.
Telomerase enzyme explained: how TERT and TERC maintain telomeres, why it matters in aging and cancer research, plus RUO peptide sourcing. Read the guide.
KLOW peptide research blend is drawing attention across California's research community. Discover its composition, COA basics, and current evidence limits.
Learn what a peptide bond is, how it forms through dehydration synthesis, and why its structure matters for research peptides. Read the full guide now.
(faqs)
